Concepedia

Publication | Open Access

Gefapixant in two randomised dose-escalation studies in chronic cough

DOIFull Paper Access

130

Citations

13

References

2020

Year

John A. Smith, Michael M. Kitt, P. Butera, Steven A. Smith, Yuping Li, Zhi Jin Xu, Kimberley Holt, Shilpi Sen, Mandel Sher, Anthony Ford
European Respiratory Journal

Abstract

P2X3 antagonism with gefapixant demonstrates anti-tussive efficacy and improved tolerability at lower doses than previously investigated. Studies of longer duration are warranted.

References

YearCitations

Page 1